Supplemental material
Report
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members
, 
, , , , , , , , , , , , , , , , , , , & show all
Sherry H. YehBiochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-2015-4563View further author information
https://orcid.org/0000-0002-2015-4563View further author information, Shravan MadireddiCancer Immunology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-7069-1252View further author information
https://orcid.org/0000-0002-7069-1252View further author information, Wadim L. MatochkoDepartments of Antibody Engineering, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0001-7387-9106View further author information
https://orcid.org/0000-0001-7387-9106View further author information, , , Mark UltschStructural Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8290-5908View further author information
https://orcid.org/0000-0002-8290-5908View further author information, Gladys De Leon BoenigStructural Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8314-1188View further author information
https://orcid.org/0000-0002-8314-1188View further author information, , , Suzie J. ScalesMolecular Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0003-2544-0283View further author information
https://orcid.org/0000-0003-2544-0283View further author information, , , , , Scot MarstersCancer Immunology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8517-0994View further author information
https://orcid.org/0000-0002-8517-0994View further author information, , , , Rafael CubasTranslational Oncology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-3450-9054View further author information
https://orcid.org/0000-0002-3450-9054View further author information, & show allRelated Research Data
Design, Construction, and In Vitro Analyses of Multivalent Antibodies
Source:
The American Association of Immunologists
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Source:
Elsevier BV
OX40 signaling is involved in the autoactivation of CD4+CD28- T cells and contributes to the pathogenesis of autoimmune arthritis.
Source:
Springer Nature
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Source:
Springer Science and Business Media LLC
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.
Source:
eScholarship, University of California
Principles of antibody-mediated TNF receptor activation.
Source:
Springer Science and Business Media LLC
Trafficking of Hyal-1 in Mouse Macrophages
Source:
Wiley
The cohesin complex regulates immunoglobulin class switch recombination
Source:
Rockefeller University Press
The storm has cleared: lessons from the CD28 superagonist TGN1412 trial.
Source:
Springer Science and Business Media LLC
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Source:
Elsevier BV
Eradication of spontaneous malignancy by local immunotherapy
Source:
American Association for the Advancement of Science (AAAS)
Reorienting the Fab domains of trastuzumab results in potent HER2 activators.
Source:
Public Library of Science (PLoS)
Compromised Ox40 Function in Cd28-Deficient Mice Is Linked with Failure to Develop Cxc Chemokine Receptor 5–Positive Cd4 Cells and Germinal Centers
Source:
Rockefeller University Press
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
Source:
Informa UK Limited
Phaser crystallographic software
Source:
International Union of Crystallography (IUCr)
TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine.
Source:
Frontiers Media S.A.
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Source:
International Union of Crystallography (IUCr)
Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody–Drug Conjugates
Source:
American Chemical Society (ACS)
Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies
Source:
Elsevier BV
The promise and challenges of immune agonist antibody development in cancer.
Source:
Springer Science and Business Media LLC
Linking provided by
